As this represents a partial reversion of the Ca2+ release phenotype to that in the absence of CaM co-expression (i.e. RyR2 alone), this suggests that CPVT-associated mutations induce a loss of inhibitory action of the channel. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.